William B. Stilley III - Dec 30, 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ William B. Stilley, III
Stock symbol
ADIL
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2023, 05:02 AM
Previous filing
Aug 23, 2022
Next filing
May 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Disposed to Issuer $0 -167K -14.03% $0.00 1.02M Dec 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the cancellation of 166,667 previously outstanding shares of restricted common stock of Adial Pharmaceuticals, Inc. originally issued on February 23, 2022.